Clinical Trials on HER2-positive Breast Cancer in Portugal
Total 135 results
-
Puma Biotechnology, Inc.CompletedHER2 Amplified Breast CancerPortugal
-
Grupo LusófonaFundação para a Ciência e a Tecnologia; Faculdade de Motricidade HumanaRecruitingBreast Cancer Female | Hormone-receptor-positive Breast CancerPortugal
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Seagen Inc.CompletedHER2 Positive Breast CancerUnited States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, H...
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
University of CoimbraIPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade...Recruiting
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Fundacao ChampalimaudNot yet recruitingTriple Negative Breast Cancer | Early Breast CancerPortugal
-
University of CoimbraFundação para a Ciência e a TecnologiaRecruitingBreast Cancer FemalePortugal
-
Centro Hospitalar Lisboa OcidentalUnknownBreast Cancer Female | Hormone Dependent NeoplasmsPortugal
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Grupo LusófonaCentro Hospitalar Universitario do Algarve; Universidade Lusófona de Humanidades... and other collaboratorsNot yet recruitingBreast Cancer | Chemotherapy EffectPortugal
-
University Institute of MaiaCentro Hospitalar de Vila Nova de Gaia/Espinho; Aveiro University; Associacao... and other collaboratorsRecruiting
-
Fundacao ChampalimaudUniversity of LisbonRecruiting
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Fundação para a Ciência e a... and other collaboratorsUnknownBreast Cancer | Breast NeoplasmsPortugal
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Institut de Radioprotection et de Surete NucleaireInstitut Català d'Oncologia; Technical University of Munich; Hospital de Santa... and other collaboratorsCompletedBreast Cancer FemaleSpain, Germany, France, Netherlands, Portugal
-
University of MinhoFoundation for Science and Technology, PortugalCompletedBreast Cancer FemalePortugal
-
The Netherlands Cancer InstituteInstitut CurieTerminatedBreast Cancer | Neoplasms, Breast | Cancer of the BreastFrance, Netherlands, Portugal, Spain
-
Associacao de Investigacao de Cuidados de Suporte...Universidad Europea de Madrid; Centro Hospitalar de Vila Nova de Gaia/Espinho; University Institute of MaiaCompletedBreast CancerPortugal
-
Associacao de Investigacao de Cuidados de Suporte...Centro Hospitalar de Vila Nova de Gaia/Espinho; Aveiro University; University...CompletedQuality of Life | Breast Cancer | Physical ExercisePortugal
-
MedSIRHoffmann-La RocheCompletedTriple Negative Breast CancerSpain, Portugal
-
Fundacao ChampalimaudEuropean Commission; Cankado GmbH; Bocconi University; INESC TEC - Institute for... and other collaboratorsRecruitingBreast CancerGermany, Israel, Italy, Portugal, Poland
-
SOLTI Breast Cancer Research GroupTerminated
-
Novartis PharmaceuticalsRecruitingBreast CancerFrance, Germany, Spain, Portugal
-
BayerActive, not recruitingHot Flashes | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerSpain, France, Belgium, United Kingdom, Hungary, Israel, Italy, Ireland, Germany, Portugal, Finland, Poland, Romania, Canada, Austria, Kazakhstan
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
MedSIRPfizerCompletedBreast CancerSpain, Portugal
-
European Organisation for Research and Treatment...Central and Eastern European Oncology Group; Grupo Oncologico Cooperativo Chileno... and other collaboratorsTerminatedBreast CancerPoland, Belgium, Netherlands, Israel, United Kingdom, Chile, Portugal
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
European Organisation for Research and Treatment...Swiss Group for Clinical Cancer Research; Swedish Breast Cancer Group; Anglo...CompletedBreast CancerFrance, Switzerland, Poland, Sweden, Belgium, Netherlands, United Kingdom, Portugal, Slovenia